Biotech

All Articles

BioMarin stops preclinical gene therapy for heart condition

.After BioMarin performed a spring well-maintained of its own pipe in April, the business has actual...

Eisai plants molecular glue SEED with $1.5 B biobucks work

.Significant Pharmas remain caught to the idea of molecular adhesive degraders. The most recent comp...

Life scientific research credit firm reveals with $600M

.A new worldwide lifestyle scientific research debt organization, referred to as Symbiotic Funds, ha...

BMS trenches TIGIT, bowing out $200M bank on Agenus bispecific

.Bristol Myers Squibb is actually axing yet another big wager from the Caforio age, ending a package...

Nuvation halts wager prevention after considering period 1 data

.After looking at period 1 record, Nuvation Bio has made a decision to stop deal with its single lea...

' Professional instinct' led FDA specialists to support Zevra's unusual ailment med

.Zevra Rehabs' uncommon health condition medicine seems to become on the course to authorization thi...

Pfizer takes $230M attacked after axing neglected DMD gene therapy

.Pfizer's phase 3 Duchenne muscle dystrophy (DMD) genetics treatment failing has blown a $230 millio...

AC Immune finds 'spots' possible in Alzheimer's medication information

.After greater than twenty years of work on neurodegenerative illness, Swiss biotech hvac Immune cas...

GSK drops ph. 2 HPV injection over lack of best-in-class prospective

.GSK has actually ditched a stage 2 human papillomavirus (HPV) vaccine from its own pipe after deter...

OS Treatments refiles $6M IPO to finance HER2 drug, preclinical ADCs

.Operating system Therapies will list on the NYSE American stock swap this morning via a $6.4 thousa...